Atlas Trials

Stage IV Papillary Thyroid Cancer

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Papillary Thyroid Cancer

RecordFirmDate
Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer (NCT00134043)National Cancer Institute (NCI)2005-12-01
Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer (NCT00118248)National Cancer Institute (NCI)2004-12-01
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy (NCT00104871)National Cancer Institute (NCI)2004-12-01
Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer (NCT00095693)National Cancer Institute (NCI)2004-10-01
Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine (NCT00098813)National Cancer Institute (NCI)2004-10-01
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074)National Cancer Institute (NCI)1999-08-01

Track Stage IV Papillary Thyroid Cancer automatically

Every clearance here is in the API, with alerts when new ones post.